- Filed
- Nov 19, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Nov 19, 2024 | 3.83B sh |
| Shares Diluted | Q2 2025 · Sep 30, 2024 | 20.13B sh |
| Shares Diluted | Q2 2025 · Sep 30, 2024 | 20.06B sh |
| Shares Diluted restated | Q2 2025 · Sep 30, 2023 | 20B sh |
| Shares Diluted restated | Q2 2025 · Sep 30, 2023 | 20B sh |
| Capex | Q2 2025 · Sep 30, 2024 | $2.93K |
| Capex | Q2 2025 · Sep 30, 2023 | $0 |
| Operating Cash Flow | Q2 2025 · Sep 30, 2024 | −$302.4K |
| Operating Cash Flow restated | Q2 2025 · Sep 30, 2023 | −$220.71K |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $208.17K |
| Cash And Equivalents | Q2 2025 · Mar 31, 2024 | $443.46K |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | −$1.57M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | −$242.52K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$256.26K |
| Stockholders Equity restated | Q2 2025 · Sep 30, 2023 | −$172.57K |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2023 | −$185.38K |
| Stockholders Equity restated | Q2 2025 · Mar 31, 2023 | −$158.8K |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $2.09M |
| Current Liabilities | Q2 2025 · Mar 31, 2024 | $1.95M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $2.86M |
| Total Liabilities | Q2 2025 · Mar 31, 2024 | $1.95M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $1.29M |
| Current Assets | Q2 2025 · Mar 31, 2024 | $1.68M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $1.3M |
| Total Assets | Q2 2025 · Mar 31, 2024 | $1.69M |
| Eps Diluted | Q2 2025 · Sep 30, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Sep 30, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Sep 30, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q2 2025 · Sep 30, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Sep 30, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q2 2025 · Sep 30, 2023 | $0.00 |
| Sga Expense | Q2 2025 · Sep 30, 2024 | $369.13K |
| Sga Expense | Q2 2025 · Sep 30, 2024 | $401.7K |
| Sga Expense restated | Q2 2025 · Sep 30, 2023 | $27.07K |
| Sga Expense restated | Q2 2025 · Sep 30, 2023 | $65.36K |
| Net Income | Q2 2025 · Sep 30, 2024 | −$407.62K |
| Net Income | Q2 2025 · Sep 30, 2024 | −$400.25K |
| Net Income | Q2 2025 · Jun 30, 2024 | $7.37K |
| Net Income restated | Q2 2025 · Sep 30, 2023 | $4.49K |
| Net Income restated | Q2 2025 · Sep 30, 2023 | −$26.89K |
| Net Income restated | Q2 2025 · Jun 30, 2023 | −$31.38K |
| Operating Income | Q2 2025 · Sep 30, 2024 | −$363.99K |
| Operating Income | Q2 2025 · Sep 30, 2024 | −$325.34K |
| Operating Income restated | Q2 2025 · Sep 30, 2023 | $28.74K |
| Operating Income restated | Q2 2025 · Sep 30, 2023 | $22.1K |
| Gross Profit | Q2 2025 · Sep 30, 2024 | $108.46K |
| Gross Profit | Q2 2025 · Sep 30, 2024 | $243.84K |
| Gross Profit restated | Q2 2025 · Sep 30, 2023 | $162.92K |
| Gross Profit restated | Q2 2025 · Sep 30, 2023 | $318.53K |
| Cost Of Revenue | Q2 2025 · Sep 30, 2024 | $252.93K |
| Cost Of Revenue | Q2 2025 · Sep 30, 2024 | $708.33K |
| Cost Of Revenue restated | Q2 2025 · Sep 30, 2023 | $280.08K |
| Cost Of Revenue restated | Q2 2025 · Sep 30, 2023 | $476.51K |
| Revenue | Q2 2025 · Sep 30, 2024 | $361.39K |
| Revenue | Q2 2025 · Sep 30, 2024 | $952.17K |
| Revenue restated | Q2 2025 · Sep 30, 2023 | $442.99K |
| Revenue restated | Q2 2025 · Sep 30, 2023 | $795.03K |